Clinical Trial Update: Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prophylactic topical agents to lessen radiation-induced dermatitis in patients undergoing breast cancer radiotherapy; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gary Morrow | Conditions: Breast Carcinoma, Pain | Phase 2 | Status: COMPLETED | Results posted: 2017-11-06